LINC02030

Across TCGA pan-cancer cohorts, LINC02030 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC02030’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where LINC02030 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02030 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

BRCA, PAAD, and KICH are the cancer types where LINC02030 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02030 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	III,IV	+0.024	.006	6	view →
PAAD	Male	All	+0.080	.015	2	view →
KICH	All	All	−0.038	.012	2	view →
HNSC	Male	All	+0.031	.033	2	view →
COAD	Male	II,III,IV	+0.023	.019	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

LINC02030–BRCA

Open the BRCA breakdown →